ZA974387B - Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases. - Google Patents

Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases.

Info

Publication number
ZA974387B
ZA974387B ZA9704387A ZA974387A ZA974387B ZA 974387 B ZA974387 B ZA 974387B ZA 9704387 A ZA9704387 A ZA 9704387A ZA 974387 A ZA974387 A ZA 974387A ZA 974387 B ZA974387 B ZA 974387B
Authority
ZA
South Africa
Prior art keywords
preparation
treatment
pharmaceutical compositions
neurodegenerative diseases
compositions useful
Prior art date
Application number
ZA9704387A
Other languages
English (en)
Inventor
Mario Pinza
Claudio Milanese
Mario Brufani
Original Assignee
Angelini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Ricerche Spa filed Critical Angelini Ricerche Spa
Publication of ZA974387B publication Critical patent/ZA974387B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9704387A 1996-05-21 1997-05-20 Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases. ZA974387B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI001013A IT1282736B1 (it) 1996-05-21 1996-05-21 Uso di derivati del p-amminofenolo per preparare composizioni farmaceutiche utili nel trattamento di malattie neurodegenerative

Publications (1)

Publication Number Publication Date
ZA974387B true ZA974387B (en) 1997-12-23

Family

ID=11374289

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704387A ZA974387B (en) 1996-05-21 1997-05-20 Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases.

Country Status (19)

Country Link
US (1) US6043285A (cs)
EP (1) EP0946162B1 (cs)
JP (1) JP2000510859A (cs)
AT (1) ATE252897T1 (cs)
AU (1) AU723004B2 (cs)
CZ (1) CZ295875B6 (cs)
DE (1) DE69725879T2 (cs)
DK (1) DK0946162T3 (cs)
EA (1) EA003251B1 (cs)
ES (1) ES2208909T3 (cs)
HU (1) HU225536B1 (cs)
IL (1) IL127044A (cs)
IT (1) IT1282736B1 (cs)
NZ (1) NZ333232A (cs)
PT (1) PT946162E (cs)
SK (1) SK284860B6 (cs)
TR (1) TR199802384T2 (cs)
WO (1) WO1997044020A1 (cs)
ZA (1) ZA974387B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI962356A1 (it) * 1996-11-13 1998-05-13 Uni Degli Studi Di Brescia D I Uso di composti derivati da molecole ad attivita' antinfiammatoria di tipo non steroideo per la prevenzione e il trattamento di
DE19911626A1 (de) * 1999-03-16 2000-09-28 Strathmann Ag & Co Induktion antiinflammatorisch wirkender Proteine durch Ammoniumionen bzw. Amino-Reste
BR9904931A (pt) * 1999-10-18 2001-06-12 Sergio Teixeira Ferreira Inibição de amiloidoses
US6664297B1 (en) * 2000-10-18 2003-12-16 Universidade Federal Do Rio De Janeiro Methods for inhibition and dissolution of amyloidoses by administration of compositions comprising 2,4-dinitrophenol
AU2003298514A1 (en) * 2002-05-17 2004-05-04 Eisai Co., Ltd. Methods and compositions using cholinesterase inhibitors
GB0310300D0 (en) * 2003-05-06 2003-06-11 Univ Belfast Nanocomposite drug delivery composition
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) * 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
EP2746251A3 (en) * 2006-09-03 2014-07-02 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of acetaminophen and related compunds with very fast skin penetration rate
KR101853971B1 (ko) * 2007-06-04 2018-05-02 테크필즈 인크 매우 높은 피부 및 막 침투율을 가지는 비스테로이드성 소염제(ｎｓａｉａ) 약물전구체 및 이들의 새로운 의약적 용도
AU2009249069A1 (en) 2008-05-20 2009-11-26 Neurogesx, Inc. Carbonate prodrugs and methods of using the same
EP2291348A4 (en) 2008-05-20 2013-05-15 Neurogesx Inc WATER-SOLUBLE ACETAMINOPHENANALOGA
RU2765463C2 (ru) 2008-12-04 2022-01-31 Чунси ЮЙ Композиции интенсивного проникновения и их применение
WO2013170655A1 (en) 2012-05-16 2013-11-21 Techfields Pharma Co., Ltd. High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
JP5855599B2 (ja) * 2013-04-30 2016-02-09 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
JP5997658B2 (ja) * 2013-05-08 2016-09-28 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用
JP6165816B2 (ja) * 2015-10-01 2017-07-19 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192753A (en) * 1991-04-23 1993-03-09 Mcgeer Patrick L Anti-rheumatoid arthritic drugs in the treatment of dementia
US5472983A (en) * 1994-04-14 1995-12-05 Centaur Pharmaceuticals, Inc. Benzamide-containing pharmaceutical compositions
US5643960A (en) * 1994-04-15 1997-07-01 Duke University Method of delaying onset of alzheimer's disease symptoms
US5756548A (en) * 1995-04-03 1998-05-26 Centaur Pharmaceuticals, Inc. Acetamidobenzamide compounds for neurodegenerative disorders

Also Published As

Publication number Publication date
ITMI961013A0 (cs) 1996-05-21
SK284860B6 (sk) 2006-01-05
NZ333232A (en) 2000-08-25
IL127044A (en) 2001-03-19
PT946162E (pt) 2004-03-31
DE69725879T2 (de) 2004-09-02
ATE252897T1 (de) 2003-11-15
CZ295875B6 (cs) 2005-11-16
AU723004B2 (en) 2000-08-17
DK0946162T3 (da) 2004-03-01
EA199801028A1 (ru) 1999-06-24
EP0946162A1 (en) 1999-10-06
US6043285A (en) 2000-03-28
IT1282736B1 (it) 1998-03-31
CZ374998A3 (cs) 1999-04-14
DE69725879D1 (de) 2003-12-04
HUP9904027A3 (en) 2000-07-28
SK159898A3 (en) 2000-04-10
HU225536B1 (en) 2007-02-28
TR199802384T2 (xx) 1999-03-22
EP0946162B1 (en) 2003-10-29
JP2000510859A (ja) 2000-08-22
ITMI961013A1 (it) 1997-11-21
IL127044A0 (en) 1999-09-22
EA003251B1 (ru) 2003-02-27
ES2208909T3 (es) 2004-06-16
HUP9904027A2 (hu) 2000-05-28
WO1997044020A1 (en) 1997-11-27
AU3092397A (en) 1997-12-09

Similar Documents

Publication Publication Date Title
IL127044A0 (en) Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases
YU37602A (sh) Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns
GB9408577D0 (en) New compound
ZA953537B (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
PL329940A1 (en) Compositions for once-a-day administration for use in treating diseases involving mediator effect of cyclooxygenase-2
PL342099A1 (en) Therapeutic agents
CA2150183A1 (en) Pharmaceutical composition for the treatment of hemorrhoidal diseases
MX9707642A (es) Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos.
EP0744176A3 (en) Methods for inhibiting bone loss
EG20672A (en) Neuroprotective compounds
NZ268110A (en) Use of ropivacaine salt in pharmaceutical compositions for the treatment of pain with sensoric block and minimal motor blockage
ZA964690B (en) Novel medical use
GB9421472D0 (en) Novel methods
NZ268914A (en) Use of efaroxan and derivatives to prepare medicaments for treating neurodegenerative diseases especially alzheimer's disease
ZA983211B (en) Use of mizolastine for preparing medication for the treatment of inflammation
MX9701528A (es) Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer.
MX9704887A (es) Composiciones farmaceuticas para el tratamiento de trastornos depresivos.
AU2067297A (en) Method for treating substance abuse